The global absorbable sutures market was valued at approximately USD 2.9 billion in 2024 and is anticipated to grow to USD 3.9 billion by 2030, with a compound annual growth rate (CAGR) of 5.3% from 2025 to 2030. This growth is fuelled by several factors, including the rising demand for minimally invasive surgeries and advancements in suture technology. The trend towards less invasive procedures facilitates quicker recovery and fewer complications, leading to increased utilization of absorbable sutures across various medical fields such as general surgery, Orthopedics, and ophthalmology. Innovations in suture materials, which enhance tensile strength and biocompatibility, are also driving market expansion.
Absorbable sutures are designed to dissolve gradually in the body, negating the need for removal. They are constructed from bioabsorbable materials such as polyglycolic acid (PGA), polylactic acid (PLA), polyglactin, and polydioxanone (PDO). These sutures offer numerous benefits, including reduced patient discomfort, lowered infection risk, and faster recovery times.
A significant factor contributing to market growth is the increasing volume of surgical procedures worldwide. The World Federation of Neurology reports that 12.0% of total neurology patients die from various conditions annually. Additionally, Medico Experts indicates that 22.6 million individuals experience neurological injuries, with 13.8 million requiring surgical intervention. The World Health Organization (WHO) projects that the number of Disability-Adjusted Life Years (DALYs) lost to neurological diseases will rise from 95 million in 2015 to 103 million by 2030 globally. This surge in neurological surgeries and the heightened demand for specially designed absorbable sutures are expected to further propel market growth.
Key Market Trends & Insights
• The North America absorbable sutures market led globally, securing 32.9% of the revenue share in 2024. According to the American Hospital Association Statistics 2024, there are approximately 6,120 operational hospitals in the U.S., conducting 40–50 million surgeries each year for conditions such as cardiovascular diseases, cancer, and trauma (NCBI, 2020).
• The Asia Pacific absorbable sutures market is experiencing rapid growth due to the increase in chronic diseases like cancer, diabetes, and cardiovascular conditions, especially in China, India, and Japan. With 1.4 million cancer diagnoses reported in India in 2022, the demand for advanced surgical tools is rising.
• By product type, the needled absorbable sterilized sutures segment held the largest revenue share at 80.9% in 2024 and is projected to grow at the fastest CAGR during the forecast period. These sutures come pre-attached to a needle, ensuring accurate and efficient application across various surgeries, including general, cardiovascular, and orthopedic procedures.
• In terms of filament type, the multifilament segment accounted for the largest revenue share of 57.0% in 2024, owing to its enhanced strength, flexibility, and ease of handling. Comprised of multiple intertwined threads, multifilament sutures offer superior knot security and are less prone to slipping during procedures.
• Regarding application, the cardiac surgery segment was the leading area in the absorbable sutures market, capturing the largest revenue share of 26.7% in 2024, driven by the high demand for heart-related surgical procedures. Absorbable sutures play a vital role in cardiac surgeries for closing incisions and securing tissue, eliminating the need for removal, which reduces patient discomfort and infection risk.
• By end use, the hospitals & clinics segment dominated the market, accounting for the largest revenue share of 44.1% in 2024. These healthcare facilities are the primary settings where absorbable sutures are extensively used in various surgical procedures, including general, orthopedic, and cardiovascular surgeries.
Order a free sample PDF of the Absorbable Sutures Market Intelligence Study, published by Grand View Research.
Market Size & Forecast
• 2024 Market Size: USD 2.9 Billion
• 2030 Projected Market Size: USD 3.9 Billion
• CAGR (2025-2030): 5.3 %
• North America: Largest market in 2024
Key Companies & Market Share Insights
The global absorbable sutures industry is characterized by intense competition, with major players like Johnson & Johnson, B Braun Melsungen AG, and Teleflex Incorporated occupying prominent positions. These leading companies are implementing a range of strategies, both organic and inorganic, including new product development, collaborations, acquisitions, mergers, and regional expansion, to address the unmet needs of their customers.
Key Players
• Johnson & Johnson
• Teleflex Incorporated
• B Braun Melsungen AG
• DemeTECH Corporation
• Lotus Surgicals Pvt Ltd
• Teleflex Incorporated
• Integra Lifesciences Corporation
• Healthium Medtech (formerly Suture India)
• Samyang Holdings Corporation
• Internacional Farmacéutica S.A. de C.V. (Atramat)
Browse Horizon Databook for Global Absorbable Sutures Size & Outlook
Conclusion
The global absorbable sutures market growth is driven by increasing demand for minimally invasive surgeries and advancements in suture technology, which promote quicker recovery and fewer complications. Absorbable sutures, made from bioabsorbable materials like PGA and PLA, dissolve gradually in the body, eliminating the need for removal and reducing patient discomfort and infection risk.
The rising number of surgical procedures worldwide significantly contributes to market expansion. Reports indicate a substantial incidence of neurological conditions, with millions requiring surgical intervention. The WHO forecasts an increase in Disability-Adjusted Life Years (DALYs) lost to neurological diseases, further driving the demand for absorbable sutures in surgical applications.